Adult Faconi Syndrome Secondary to Light Chain Gammopathy: Clinicopathologic Heterogeneity and Unnsual Features in 11 Patients
T. Messiaen(Sorbonne Université), Pierre Ronco(Inserm), Philippe Zaoui(Centre Hospitalier Universitaire de Grenoble), Frank Bridoux(Université de Poitiers), Pierre Aucouturies(Inserm), Jacques Pourrat(Hôpital Rangueil), B. Mougenot(Assistance Publique – Hôpitaux de Paris), Sophie Déret(Assistance Publique – Hôpitaux de Paris), Puilippe dequiedt(Inserm), Jean-Jacques Dion(Inserm), Philippe Vanhille(Centre Hospitalier de Valenciennes), Raïfah Makdassi(Inserm), Guy Touchard(Centre Hospitalier Universitaire de Poitiers)
Cited by 229
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809